Procter & Gamble has extended its dividend streak to 69 consecutive years of increases and has paid dividends for 135 years. The current yield stands at 2.9%, underpinned by approximately $12 billion in free cash flow generated over the trailing 12 months and a conservative payout ratio of 61%. In Q1 2026, the company reported net sales of $22.4 billion (up 3% year-over-year) and net earnings of $4.8 billion (up 20%). For the full fiscal year 2025, P&G delivered net sales of $84.3 billion (flat) and net earnings of $16 billion (up 7%), demonstrating resilient demand for essential consumer products even as foreign exchange headwinds persisted.

During the third quarter, Farmers & Merchants Investments Inc. reduced its stake by 6,300 shares, leaving it with 138,611 shares valued at $21.3 million. This follows a wave of small‐scale positions by other asset managers, including new stakes by Halbert Hargrove and Nova Wealth Management. Meanwhile, senior insiders have trimmed holdings: CEO Gary A. Coombe sold 3,535 shares and COO Shailesh Jejurikar divested 3,986 shares in early October, contributing to total insider sales of 30,308 shares valued at $4.6 million over the past three months.

Procter & Gamble topped Q1 consensus with EPS of $1.99 versus $1.90 expected, alongside revenue of $22.39 billion versus $22.23 billion forecast. The company reported a return on equity of 32.6% and a net margin of 19.7%. Management set fiscal 2026 EPS guidance between $6.83 and $7.10, compared with a consensus estimate of $6.91. Analysts maintain a Moderate Buy consensus, with 13 Buy ratings and 10 Hold ratings. Price targets range from $151 (Equal Weight) to $176 (Buy), with a consensus target of $171.38, reflecting confidence in P&G’s ability to navigate cost pressures and sustain growth in its core categories.